Publication

Methyl-3-indolylacetate inhibits cancer cell invasion by targeting MEK1/2-ERK1/2 signaling pathway

Zhang, S.Huang, Q.
Shen, H.-M.
Ong, C.-N.
Li, Z.
Wu, X.
Citations
Altmetric:
Alternative Title
Abstract
Keywords
Source Title
Molecular Cancer Therapeutics
Publisher
Series/Report No.
Organizational Units
Rights
Date
2006
DOI
10.1158/1535-7163.MCT-06-0240
Type
Article
Related Datasets
Related Publications